ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
119.137,86
-0,44%
S&P 500
5.473,23
0,77%
US Dollar vs BRL
5,4217
-0,07%
Bitcoin
65.848,77
-0,96%
Brent Oil
83,865
-0,04%
Registration Strip Icon for pro Negocie como um profissional: Aproveite discussões em tempo real e ideias que movimentam o mercado para superar a concorrência.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Heat Biologics Inc (HTBX)

  7. Heat Biologics Inc (HTBX) Notícias

HTBX

Heat Biologics (HTBX)

Heat Biologics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:HTBX
DataHoraFonteTítuloCódigoCompanhia
15/05/202317:34Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:HTBXHeat Biologics Inc
15/05/202317:28Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:HTBXHeat Biologics Inc
31/03/202317:15Edgar (US Regulatory)Annual Report (10-k)NASDAQ:HTBXHeat Biologics Inc
30/12/202218:06Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:HTBXHeat Biologics Inc
09/12/202219:04Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HTBXHeat Biologics Inc
06/06/202217:29Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:HTBXHeat Biologics Inc
18/03/202208:35TipRanksAnalysts Are Bullish on Top Healthcare Stocks: Biolase (BIOL), Heat Biologics (HTBX)NASDAQ:HTBXHeat Biologics Inc
11/03/202208:33Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-a12b/a)NASDAQ:HTBXHeat Biologics Inc
11/02/202219:17Edgar (US Regulatory)Notification Filed by a National Securities Exchange to Report the Removal From Listing and Registration of Matured , Redeemed or Retired Securities (25)NASDAQ:HTBXHeat Biologics Inc
08/02/202219:04Edgar (US Regulatory)Certification by the Exchange Approving Securities for Listing (cert)NASDAQ:HTBXHeat Biologics Inc
02/02/202218:05GlobeNewswire Inc.Heat Biologics Announces Planned Transfer to the NYSE AmericanNASDAQ:HTBXHeat Biologics Inc
31/01/202209:30GlobeNewswire Inc.Elusys Therapeutics Finalizes HHS Contract to Deliver ANTHIM®, Its Treatment for Inhalation Anthrax, to the U.S. Department of Health and Human ServicesNASDAQ:HTBXHeat Biologics Inc
12/01/202210:00GlobeNewswire Inc.Heat Biologics Announces New PTX-35 Preclinical Data in Organ Transplantation and Provides Update on HS-110NASDAQ:HTBXHeat Biologics Inc
22/12/202109:05TipRanksB.Riley Financial Thinks Heat Biologics’ Stock is Going to RecoverNASDAQ:HTBXHeat Biologics Inc
21/12/202109:30GlobeNewswire Inc.Heat Biologics Announces Planned Acquisition of Elusys TherapeuticsNASDAQ:HTBXHeat Biologics Inc
30/11/202109:30GlobeNewswire Inc.Heat Biologics Unveils RapidVax®, A Novel Cellular Vaccine Platform Targeting Known and Unknown Emerging Biological ThreatsNASDAQ:HTBXHeat Biologics Inc
10/11/202118:05GlobeNewswire Inc.Heat Biologics Provides Third Quarter 2021 Business UpdateNASDAQ:HTBXHeat Biologics Inc
06/10/202108:30GlobeNewswire Inc.Heat Biologics Appoints Paul Tebbey as Senior Vice President of Product Development and Portfolio StrategyNASDAQ:HTBXHeat Biologics Inc
15/09/202108:30GlobeNewswire Inc.Heat Biologics CEO to Present at the Cantor Fitzgerald Global Healthcare Conference on September 29thNASDAQ:HTBXHeat Biologics Inc
09/09/202109:30GlobeNewswire Inc.Heat Biologics to Present at the H.C. Wainwright 23rd Annual Global Investment ConferenceNASDAQ:HTBXHeat Biologics Inc
30/08/202108:30GlobeNewswire Inc.Heat Biologics to Provide Corporate UpdateNASDAQ:HTBXHeat Biologics Inc
26/08/202109:00GlobeNewswire Inc.Heat Biologics Unveils Skunkworx Bio, New Drug Discovery SubsidiaryNASDAQ:HTBXHeat Biologics Inc
23/08/202109:00GlobeNewswire Inc.Heat Biologics Announces Addition of Former US Senator Mark Pryor to Biothreat Advisory BoardNASDAQ:HTBXHeat Biologics Inc
19/08/202110:00GlobeNewswire Inc.Heat Biologics Announces New Additions to Biothreat Advisory BoardNASDAQ:HTBXHeat Biologics Inc
18/08/202109:00GlobeNewswire Inc.Heat Biologics Announces Formation of Biothreat Advisory BoardNASDAQ:HTBXHeat Biologics Inc
11/08/202117:05GlobeNewswire Inc.Heat Biologics Provides Second Quarter 2021 Business UpdateNASDAQ:HTBXHeat Biologics Inc
09/08/202108:30GlobeNewswire Inc.Heat Biologics Announces Groundbreaking for New San Antonio FacilityNASDAQ:HTBXHeat Biologics Inc
03/08/202117:43Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:HTBXHeat Biologics Inc
28/06/202108:30GlobeNewswire Inc.Heat Biologics Joins Russell Microcap® IndexNASDAQ:HTBXHeat Biologics Inc
23/06/202108:30GlobeNewswire Inc.Heat Biologics Announces Significant Expansion of R&D and Pre-Clinical Capabilities at Corporate HeadquartersNASDAQ:HTBXHeat Biologics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:HTBX

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
OIBR3
OI ON
BOV
AMAR3
LOJAS MARISA ON
BOV
AMER3
Americanas ON
BOV
TELB4
TELEBRAS PN
BOV
RCSL3
RECRUSUL ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados